Skip to main content
2024 ISPE Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Evaluation Video

Pregnancy Potpourri

Tuesday, August 27, 2024
1:00 PM – 2:30 PM CEST
Location:Room XV

Presentations:

  • 1:00 PM – 1:15 PM CEST
    Characterizing perinatal treatment patterns and outcomes in rheumatologic disease: A retrospective cohort study in a US health insurance claims database

    Presenting Author: Melanie H. Jacobson, PhD, MPH (she/her/hers) – Johnson and Johnson Innovative Medicine

    Co-Author: Rupa Makadia, PhD – Global Epidemiology, Johnson & Johnson Innovative Medicine

    Co-Author: Nathan E. Hall, MS – Johnson & Johnson

    Co-Author: Jill Hardin – Johnson & Johnson

    Co-Author: Sicong Huang, MD, MS – Janssen Research & Development, LLC

    Co-Author: Anna Ostropolets, MD, PhD – Johnson and Johnson Innovative Medicine

    Co-Author: Ran Sun – Johnson & Johnson Innovative Medicine

    Co-Author: Rebecca Zaha – Johnson and Johnson Innovative Medicine

    Co-Author: Alexis Krumme, ScD (she/her/hers) – Johnson & Johnson, Titusville, New Jersey, USA

  • 1:15 PM – 1:30 PM CEST
    Association of Non-Steroidal Anti-Inflammatory Drug Use during Pregnancy and Miscarriage: A Norwegian Registry Linkage Study

    Presenting Author: Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway

    Co-Author: Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway

    Co-Author: Hilde M. Engjom, PhD – Norwegian Institute of Public Health

    Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway

  • 1:30 PM – 1:45 PM CEST
    Adverse pregnancy outcomes associated with in utero exposure to multiple sclerosis disease-modifying therapies in France: a nationwide cohort study

    Presenting Author: Morgane Swital, MSc – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)

    Co-Author: Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

    Co-Author: Sara Miranda, PharmD – EPI-PHARE (ANSM/CNAM)

    Co-Author: Jérémie Botton, PhD, PharmD, MPH – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

    Co-Author: Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

  • 1:45 PM – 2:00 PM CEST
    Leveraging human genetics to inform the effect of blood pressure lowering drugs on adverse pregnancy outcomes

    Presenting Author: Maria Carolina Borges – University of Bristol

    Co-Author: Qian Yang – University of Bristol

    Co-Author: Nancy McBride – University of Bristol

    Co-Author: Marwa Al Arab – University of Bristol

    Co-Author: Christy Burden, MBChB, BSc, MD, MRCOG – University of Bristol

    Co-Author: Kate Birchenall – University of Bristol

    Co-Author: Ana Luiza Soares – University of Bristol

    Co-Author: Tom Bond – University of Bristol

    Co-Author: Maria C. Magnus – Norwegian Institute of Public Health

    Co-Author: Deborah Lawlor – University of Bristol

  • 2:00 PM – 2:15 PM CEST
    Comparing the Risk of Adverse Infant Outcomes Among Pregnancies with and without COVID-19 in the Sentinel System

    Presenting Author: Mayura Shinde, DrPH – Harvard Pilgrim Health Care Institute

    Co-Author: Austin Cosgrove – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA

    Co-Author: Maria E. Kempner – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA

    Co-Author: Jennifer G. Lyons – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA

    Co-Author: Jolene Mosley – Department of Population Medicine, Harvard Pilgrim HealthCare Institute, Boston, MA

    Co-Author: Andrew Petrone – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachuetts, USA

    Co-Author: Elizabeth Messenger-Jones – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA

    Co-Author: Maria Lewis – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA

    Co-Author: Yueqin Zhao, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD

    Co-Author: Leyla Sahin, MD – Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA

    Co-Author: José J. Hernández-Muñoz, RPh, MPH, MSc, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA

    Co-Author: Darren Toh, ScD – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA

    Co-Author: Wei Hua, MSc, MHS, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA

  • 2:15 PM – 2:30 PM CEST
    Major Congenital Malformations After First-Trimester Exposure to Smoking Cessation Pharmacotherapies: A Population-based Study in Australia, New Zealand, Norway and Sweden

    Presenting Author: Duong T. Tran, PhD – National Drug and Alcohol Research Centre

    Co-Author: Jacqueline M. Cohen, PhD (she/her/hers) – Norwegian Institute of Public Health

    Co-Author: Sarah Donald – University of Otago

    Co-Author: Annelies L. Robijn, PhD MSc BSc – National Drug and Alcohol Research Centre

    Co-Author: Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.

    Co-Author: Kari Furu, MPH, PhD (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.

    Co-Author: Lianne Parkin, MB ChB, PhD – University of Otago

    Co-Author: Sallie-Anne Pearson, PhD – UNSW Sydney

    Co-Author: Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.

    Co-Author: Helga Zoega – Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.

    Co-Author: Nicholas Zwar – Bond University

    Co-Author: Alys Havard, PhD (she/her/hers) – National Drug and Alcohol Research Centre